This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2025
Delivered in a 100% Virtual FormatEastern Daylight Time (EST)

Train Your Entire Team at BPI COVID-19 Therapeutic Development & Production Virtual 2021

Provide your entire department, division or company across several sites with full access to BPI COVID-19 Therapeutic Development & Production by purchasing a company license, valid for anywhere between 10 to 1000+ attendees at an affordable price per person.

Apply for company license pricing today to keep your team up-to-date on today's novel science and technologies designed to accelerate the development and production of COVID-19 vaccines and therapeutics.

INNOVATIVE SCIENCE

Access 20+ scientific case studies and new data presentations designed to help you accelerate the development and production of COVID-19 vaccines and therapeutics. Gain answers to your challenges by participating in interactive live speaker Q&A sessions. Plus, receive 30-day on-demand access to re-watch presentations after the event.

NOVEL TECHNOLOGIES

Improve efficiencies across all phases of bioprocessing by learning about today’s new technologies from leading solution providers serving the entire spectrum of biopharmaceutical development and production.

MAKE NEW CONNECTIONS

Access the full attendee list pre-event to arrange meeting requests or exchange private messages. Our AI-powered matchmaking software recommends contacts for you based on similar interests, making it easier than ever to find your next partner or customer.

PRESENT YOUR RESEARCH

Share your latest research by presenting a scientific poster as part of the BPI COVID-19 Therapeutic Development & Production virtual event. Posters are displayed for all registered attendees to view and discuss.